Toronto company selling Valiant, an AI-and-robotics platform that autonomously designs, tests and optimizes pharmaceutical formulations for drug developers.
Canadian innovation builds a brighter tomorrow.
Toronto company selling Valiant, an AI-and-robotics platform that autonomously designs, tests and optimizes pharmaceutical formulations for drug developers.
Federal corporation Intrepid Labs Inc. (incorporated 2023-05-30), status Active, registered/extra-provincial office in Toronto, Ontario. ised-isde.canada.ca
Emerged from stealth May 12, 2025 with $11M+ USD raised: a $4M pre-seed led by Radical Ventures with Propagator Ventures participating, plus a $7M seed led by AVANT BIO. biospace.com
A University of Toronto spinout founded in 2023, headquartered at the MaRS Discovery District in Toronto. biospace.com
Named to Medicine Maker's 2026 Power List, recognizing CEO Dr. Christine Allen's work on AI's role in drug development. intrepidlabs.tech
Has forged partnerships with multiple drug developers, including large global pharmaceutical companies, CROs and small/mid-sized biotechs, though no individual partner names are disclosed. biospace.com
Products Intrepid Labs publishes on its own site. Each card links to the page it was taken from.
AI-driven autonomous drug formulation platform
Company describes a modular, AI-driven robotic lab that combines machine learning, real-time experiment planning and robotic execution to explore drug formulation designs, cutting formulation timelines from months to days.
Learn moreAnnounced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
May 12, 2025
Investors: AVANT BIO
Government support actually received. Unpublished amounts are left out.
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
Intrepid Labs published research demonstrating how agentic AI can identify more target-product-profile-matched formulations within the same experimental budget.
Intrepid Labs emerged from stealth with the Valiant platform, disclosing a $7M seed round led by AVANT BIO following an earlier $4M pre-seed led by Radical Ventures with Propagator Ventures, for total funding of over $11M USD.
Sourced from the company's own pages or announcements.
Dr. Christine Allen
Co-Founder & Chief Executive Officer
Dr. Pauric Bannigan
Co-Founder & Chief Scientific Officer
Dr. Riley Hickman
Co-Founder & Director of Research and Development
Terms the company uses about its own work.
Other companies in AI.
Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.
